OncoSynergy, Inc. is a clinical-stage, physician-founded biopharmaceutical company headquartered in Stamford, Connecticut, focused on developing innovative oncology therapies to address unmet medical needs.
Subscribe to see ONCOSYNERGY, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ONCOSYNERGY, INC. is a company headquartered in Stamford, United States. It has raised at least $13.3M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round raised $6.6M in May 2026. Xcout tracks 7 named people at ONCOSYNERGY, INC., including Gregory Wilson (Consulting CFO).
As of 16 November 2026. Source: Xcout Intel.
1 more named person on record for ONCOSYNERGY, INC., with roles, board committees and tenure — see the full roster →
At least $13.3M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6.6M | — | |
| SEC Form D filing | $3.5M | — | |
| SEC Form D filing | $3.3M | — | |
| Series A | Undisclosed | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ONCOSYNERGY, INC.'s closest competitors — see the full list of competitors and alternatives →
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Newtown, Pennsylvania. Founded in 1998, the company specializes in oncology therapeutics by discovering and developing novel anti-cancer products for patients.
iOncologi, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of intractable solid tumors.
Oncternal Therapeutics, Inc. is a clinical-stage oncology company founded in 2013 and headquartered in San Diego, California, focused on developing new cancer treatments.
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Elevation Oncology, Inc. is an innovative oncology company focused on discovering and developing targeted therapies for cancer, with corporate locations in Boston and New York.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ONCOSYNERGY, INC.? Suggest a correction · Work at ONCOSYNERGY, INC.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.